Aurora Cannabis Inc.
TSX:ACB.TODrug Manufacturers - Specialty & Generic
+$0.02 today
- Market cap
- $414.85M
- Beta
- 1.34
- P/E (TTM)
- -3.2
- EPS (TTM)
- -$1.31
Volume 0.32M
Average 0.42M
ACB.TO Operating Margin
Operating income as a percentage of revenue, showing the profitability of core operations.
Aurora Cannabis Inc.TSX: ACB.TO
Operating Margin · Q4 FY2026 · quarter ended Mar 2026
Operating margin narrows to -66.1%
Operating margin was -66.1% in Q4 FY2026, down 32.5 pp from a year earlier. On a trailing-twelve-month basis it was -23.0%, down 24.5 pp year over year. Over 3 fiscal years it widened by 58.2 pp.
Context
- Operating margin widened in 2 of the last 3 fiscal years.
What to watch
Whether operating margin reaches the consensus estimate from 4 analysts of -5.7% for the fiscal year ending Mar 2027, up from -50.8% in FY2026.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -66.1%-27.6 pp QoQ
- Last fiscal yearMar 2026
- -50.8%-52.2 pp YoY
- LTMMar 2026
- -23.0%-24.5 pp YoY
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Operating Margin history
Percent of revenue · from the income statement
- Latest · FY2026
- -50.8%
- Year-over-year change
- -52.2pp
| Period | Period end | Operating Margin | YoY change |
|---|---|---|---|
| FY2026 | 2026-03-31 | -50.8% | -52.2pp |
| FY2025 | 2025-03-31 | 1.4% | +18.6pp |
| FY2024 | 2024-03-31 | -17.2% | +91.8pp |
| FY2023 | 2023-03-31 | -109.0% | -4.4pp |
| FY2022 | 2022-06-30 | -104.6% | — |
Operating Margin vs competitors
How ACB.TO compares with its peers on the latest reported figures
- ACB.TO's LTM Mar 2026 operating margin of -23.0% is the 5th highest of the 8 companies compared; the peer median is -11.9%.
- Its year-over-year change of -24.5 pp is the 7th highest of 8, against a peer median of +20.0 pp.
- Over three fiscal years its change of +58.2 pp compares with a peer median of +50.8 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Mar 2026 | 38.8% | +14.8 pp | -25.5 pp | |
| LTM Mar 2026 | 16.8% | +21.8 pp | +26.7 pp | |
| LTM Mar 2026 | 13.5% | -4.4 pp | +73.4 pp | |
| LTM Mar 2026 | -11.9% | +26.8 pp | +1457.4 pp | |
| LTM Mar 2026 | -23.0% | -24.5 pp | +58.2 pp | |
| LTM Mar 2026 | -23.5% | +20.0 pp | +93.1 pp | |
| LTM Mar 2026 | -38.6% | -26.4 pp | — | |
| LTM Mar 2026 | -412.3% | +216.5 pp | +28.2 pp | |
| Peer median (excluding ACB.TO) | -11.9% | +20.0 pp | +50.8 pp | |
Competitors are the stored peer set for ACB.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2022 Jun 2022 | FY2023 Mar 2023 | FY2024 Mar 2024 | FY2025 Mar 2025 | FY2026 Mar 2026 |
|---|---|---|---|---|---|
| Revenue | 221.34M | 233.29M | 270.28M | 343.29M | 320.59M |
| Cost of Revenue | 200.11M | 297.65M | 138.82M | 155.69M | 303.89M |
| Gross Profit | 21.23M | (64.36M) | 131.46M | 187.61M | 16.7M |
| Gross Margin | 9.6% | -27.6% | 48.6% | 54.6% | 5.2% |
| Research & Development | 10.39M | 6.56M | 3.57M | 3.68M | 4.02M |
| Selling, General & Admin | 188.99M | 183.4M | 156.88M | 166.47M | 173.5M |
| Operating Expenses | 252.67M | 189.96M | 177.91M | 182.66M | 179.5M |
| Depreciation & Amortization | 93.66M | 43.57M | 33.07M | 22.55M | 14.19M |
| EBITDA | (1.55B) | (210.74M) | (12.34M) | 51.35M | (162.79M) |
| EBITDA Margin | -702.4% | -90.3% | -4.6% | 15.0% | -50.8% |
| Operating Income | (231.45M) | (254.32M) | (46.45M) | 4.95M | (162.79M) |
| Operating Margin | -104.6% | -109.0% | -17.2% | 1.4% | -50.8% |
| Interest Income | 4.51M | 19M | 12.81M | 11.51M | 5.85M |
| Interest Expense | 71.81M | 39.46M | 14.19M | 8.42M | 1.81M |
| Other Income / Expenses | (1.49B) | (41.1M) | (13.15M) | 15.43M | 106.27M |
| Income Before Tax | (1.72B) | (295.42M) | (59.6M) | 20.38M | (56.52M) |
| Pre-Tax Margin | -777.1% | -126.6% | -22.1% | 5.9% | -17.6% |
| Income Tax Expense | (2.14M) | (20.32M) | (554K) | 4.62M | 2.1M |
| Net Income | (1.72B) | (265.33M) | (69.33M) | 1.59M | (121.76M) |
| Net Margin | -776.0% | -113.7% | -25.6% | 0.5% | -38.0% |
| EPS (Basic) | (79.92) | (8.17) | (1.28) | 0.03 | (2.15) |
| EPS (Diluted) | (79.92) | (8.17) | (1.28) | 0.03 | (2.15) |
| Weighted Avg Shares | 21.49M | 32.27M | 51.26M | 54.88M | 56.71M |
| Weighted Avg Shares (Diluted) | 21.49M | 32.27M | 51.26M | 55.75M | 56.71M |
Aurora Cannabis Inc.
TSX:ACB.TO
Intrinsic Alpha fair value
Locked
Current Price
$6.31
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.